Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP682083.RAkGDZZ2wIJXr-JBt1Xth98F6hpoc7jNHE8h7ETAOlCaM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP682083.RAkGDZZ2wIJXr-JBt1Xth98F6hpoc7jNHE8h7ETAOlCaM130_assertion type Assertion NP682083.RAkGDZZ2wIJXr-JBt1Xth98F6hpoc7jNHE8h7ETAOlCaM130_head.
- NP682083.RAkGDZZ2wIJXr-JBt1Xth98F6hpoc7jNHE8h7ETAOlCaM130_assertion description "[Since even small increases in enzyme activity can dramatically influence the clinical phenotype of MPS VI, our study suggests that pharmacological read-through may be combined with ERT potentially increasing therapeutic efficacy in those patients bearing nonsense ARSB mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP682083.RAkGDZZ2wIJXr-JBt1Xth98F6hpoc7jNHE8h7ETAOlCaM130_provenance.
- NP682083.RAkGDZZ2wIJXr-JBt1Xth98F6hpoc7jNHE8h7ETAOlCaM130_assertion evidence source_evidence_literature NP682083.RAkGDZZ2wIJXr-JBt1Xth98F6hpoc7jNHE8h7ETAOlCaM130_provenance.
- NP682083.RAkGDZZ2wIJXr-JBt1Xth98F6hpoc7jNHE8h7ETAOlCaM130_assertion SIO_000772 22971959 NP682083.RAkGDZZ2wIJXr-JBt1Xth98F6hpoc7jNHE8h7ETAOlCaM130_provenance.
- NP682083.RAkGDZZ2wIJXr-JBt1Xth98F6hpoc7jNHE8h7ETAOlCaM130_assertion wasDerivedFrom befree-20140225 NP682083.RAkGDZZ2wIJXr-JBt1Xth98F6hpoc7jNHE8h7ETAOlCaM130_provenance.
- NP682083.RAkGDZZ2wIJXr-JBt1Xth98F6hpoc7jNHE8h7ETAOlCaM130_assertion wasGeneratedBy ECO_0000203 NP682083.RAkGDZZ2wIJXr-JBt1Xth98F6hpoc7jNHE8h7ETAOlCaM130_provenance.